|
1
|
Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea.
|
Thromb Res
|
2008
|
1.48
|
|
2
|
Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study.
|
Cancer Genet Cytogenet
|
2009
|
1.15
|
|
3
|
Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells.
|
Mol Oncol
|
2008
|
1.11
|
|
4
|
Non-A type nucleophosmin 1 gene mutation predicts poor clinical outcome in de novo adult acute myeloid leukemia: differential clinical importance of NPM1 mutation according to subtype.
|
Int J Hematol
|
2009
|
1.03
|
|
5
|
Advanced glycation end product (AGE)-induced proliferation of HEL cells via receptor for AGE-related signal pathways.
|
Int J Oncol
|
2008
|
0.98
|
|
6
|
Prognostic implications of the immunophenotype in biphenotypic acute leukemia.
|
Leuk Lymphoma
|
2008
|
0.92
|
|
7
|
Case of complete recovery of pancytopenia after treatment of hypopituitarism.
|
Ann Hematol
|
2003
|
0.91
|
|
8
|
First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma.
|
Leuk Lymphoma
|
2006
|
0.91
|
|
9
|
Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis.
|
Int J Oncol
|
2003
|
0.89
|
|
10
|
Clinical dissection of multicentric Castleman disease.
|
Leuk Lymphoma
|
2011
|
0.88
|
|
11
|
P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.
|
Haematologica
|
2007
|
0.88
|
|
12
|
Monensin-mediated growth inhibition of SNU-C1 colon cancer cells via cell cycle arrest and apoptosis.
|
Int J Oncol
|
2003
|
0.87
|
|
13
|
Hematological manifestations of human immunodeficiency virus infection and the effect of highly active anti-retroviral therapy on cytopenia.
|
Korean J Hematol
|
2011
|
0.87
|
|
14
|
Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
|
Cancer
|
2003
|
0.86
|
|
15
|
Association of human leukocyte antigen class II alleles with response to immunosuppressive therapy in Korean aplastic anemia patients.
|
Hum Immunol
|
2010
|
0.86
|
|
16
|
Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib.
|
Ann Hematol
|
2010
|
0.86
|
|
17
|
PAX5 deletion is common and concurrently occurs with CDKN2A deletion in B-lineage acute lymphoblastic leukemia.
|
Blood Cells Mol Dis
|
2011
|
0.84
|
|
18
|
Antileukemic effect of a synthetic vitamin D3 analog, HY-11, with low potential to cause hypercalcemia.
|
Int J Oncol
|
2008
|
0.84
|
|
19
|
Clinical features of Waldenstrom macroglobulinemia in Korea.
|
Korean J Intern Med
|
2004
|
0.83
|
|
20
|
Recombinant human epidermal growth factor on oral mucositis induced by intensive chemotherapy with stem cell transplantation.
|
Am J Hematol
|
2012
|
0.82
|
|
21
|
The induction of apoptosis by a combined 1,25(OH)2D3 analog, EB1089 and TGF-beta1 in NCI-H929 multiple myeloma cells.
|
Int J Oncol
|
2002
|
0.82
|
|
22
|
Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells.
|
Anticancer Drugs
|
2008
|
0.82
|
|
23
|
Utility of ELISA optical density values and clinical scores for the diagnosis of and thrombosis prediction in heparin-induced thrombocytopenia.
|
Korean J Lab Med
|
2011
|
0.82
|
|
24
|
Incidence of submicroscopic deletions vary according to disease entities and chromosomal translocations in hematologic malignancies: investigation by fluorescence in situ hybridization.
|
Cancer Genet Cytogenet
|
2007
|
0.82
|
|
25
|
Interpretation of submicroscopic deletions of the BCR or ABL gene should not depend on extra signal-FISH: problems in interpretation of submicroscopic deletion of the BCR or ABL gene with extra signal-FISH.
|
Genes Chromosomes Cancer
|
2005
|
0.81
|
|
26
|
The use of the complement inhibitor eculizumab (Soliris®) for treating Korean patients with paroxysmal nocturnal hemoglobinuria.
|
Korean J Hematol
|
2010
|
0.81
|
|
27
|
Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2011
|
0.81
|
|
28
|
Monensin-mediated growth inhibition in human lymphoma cells through cell cycle arrest and apoptosis.
|
Br J Haematol
|
2002
|
0.81
|
|
29
|
Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA).
|
Leuk Res
|
2010
|
0.81
|
|
30
|
The treatment of severe aplastic anemia: outcomes of bone marrow transplantation and immunosuppressive therapy in a single institution of Korea.
|
J Korean Med Sci
|
2003
|
0.80
|
|
31
|
Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8.
|
Jpn J Clin Oncol
|
2010
|
0.79
|
|
32
|
Impact of cytokine gene polymorphisms on risk and treatment outcomes of aplastic anemia.
|
Ann Hematol
|
2010
|
0.79
|
|
33
|
Adult patients with t(8;21) acute myeloid leukemia had no superior treatment outcome to those without t(8;21): a single institution's experience.
|
Ann Hematol
|
2003
|
0.79
|
|
34
|
Impact of vitamin D receptor gene polymorphisms on clinical outcomes of HLA-matched sibling hematopoietic stem cell transplantation.
|
Clin Transplant
|
2011
|
0.79
|
|
35
|
Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center.
|
Hematology
|
2011
|
0.78
|
|
36
|
Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.
|
Clin Transplant
|
2007
|
0.78
|
|
37
|
Polymorphisms of the methylenetetrahydrofolate reductase gene and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.
|
Ann Hematol
|
2006
|
0.78
|
|
38
|
Allogeneic stem cell transplantation for patients with advanced hematological malignancies: comparison of fludarabine-based reduced intensity conditioning versus myeloablative conditioning.
|
J Korean Med Sci
|
2007
|
0.78
|
|
39
|
Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non-Hodgkin lymphoma.
|
Am J Hematol
|
2012
|
0.78
|
|
40
|
Radioprotective effects of various cytokines in peripheral blood mononuclear cells and C3H mice.
|
Oncol Rep
|
2005
|
0.78
|
|
41
|
Molecular mechanisms of cellular proliferation in acute myelogenous leukemia by leptin.
|
Oncol Rep
|
2010
|
0.78
|
|
42
|
Clinical differentiation of acute cutaneous graft-versus-host disease from drug hypersensitivity reactions.
|
J Am Acad Dermatol
|
2011
|
0.78
|
|
43
|
Central pontine myelinolysis in a patient with acute lymphoblastic leukemia after hematopoietic stem cell transplantation: a case report.
|
J Korean Med Sci
|
2008
|
0.78
|
|
44
|
Molecular characterization and prognostic significance of FLT3 in CML progression.
|
Leuk Res
|
2009
|
0.77
|
|
45
|
Establishment of a new Glivec-resistant chronic myeloid leukemia cell line, SNUCML-02, using an in vivo model.
|
Exp Hematol
|
2010
|
0.77
|
|
46
|
Fludarabine, cytarabine, and attenuated-dose idarubicin (m-FLAI) combination therapy for elderly acute myeloid leukemia patients.
|
Am J Hematol
|
2012
|
0.77
|
|
47
|
A pilot study of bortezomib in Korean patients with relapsed or refractory myeloma.
|
J Korean Med Sci
|
2005
|
0.77
|
|
48
|
Anti-leukemic effect of a synthetic compound, (±) trans-dihydronarciclasine (HYU-01) via cell-cycle arrest and apoptosis in acute myeloid leukemia.
|
APMIS
|
2012
|
0.77
|
|
49
|
High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization.
|
Korean J Intern Med
|
2005
|
0.77
|
|
50
|
Multicentric Castleman's disease complicated by tumor lysis syndrome.
|
Ann Hematol
|
2004
|
0.77
|
|
51
|
GSTT1 copy number gain is a poor predictive marker for escalated-dose imatinib treatment in chronic myeloid leukemia: genetic predictive marker found using array comparative genomic hybridization.
|
Cancer Genet Cytogenet
|
2010
|
0.77
|
|
52
|
Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation.
|
Ann Hematol
|
2011
|
0.77
|
|
53
|
Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement.
|
Ann Hematol
|
2009
|
0.77
|
|
54
|
DAAM2 polymorphism is closely related to the clinical outcomes of allogeneic hematopoietic stem cell transplantation.
|
Ann Hematol
|
2011
|
0.76
|
|
55
|
Induction of cytotoxic T lymphocytes by dendritic cells pulsed with murine leukemic cell RNA.
|
Am J Hematol
|
2004
|
0.76
|
|
56
|
RANTES polymorphisms and the risk of graft-versus-host disease in human leukocyte antigen-matched sibling allogeneic hematopoietic stem cell transplantation.
|
Acta Haematol
|
2012
|
0.76
|
|
57
|
Increased BCR promoter DNA methylation status strongly correlates with favorable response to imatinib in chronic myeloid leukemia patients.
|
Oncol Lett
|
2010
|
0.75
|
|
58
|
Allogeneic hematopoietic cell transplantation for acute leukemia in first relapse or second remission.
|
Korean J Hematol
|
2010
|
0.75
|
|
59
|
Patient HSP70-hom TG haplotype is associated with decreased transplant-related mortality and improved survival after sibling HLA-matched hematopoietic stem cell transplantation.
|
Clin Transplant
|
2010
|
0.75
|
|
60
|
Combination of SK-7041, one of novel histone deacetylase inhibitors, and STI571-induced synergistic apoptosis in chronic myeloid leukemia.
|
Anticancer Drugs
|
2007
|
0.75
|
|
61
|
Pneumatosis intestinalis with pneumoperitoneum mimicking intestinal perforation in a patient with myelodysplastic syndrome after hematopoietic stem cell transplantation.
|
Korean J Intern Med
|
2007
|
0.75
|
|
62
|
Hematopoietic stem cell transplantation after posttransplant lymphoproliferative disorder.
|
J Korean Med Sci
|
2010
|
0.75
|
|
63
|
Cost analysis of iron-related complications in a single institute.
|
Korean J Intern Med
|
2009
|
0.75
|
|
64
|
Extramedullary relapse confirmed by fluorescence in situ hybridization study of an ear mass in acute promyelocytic leukemia.
|
Int J Hematol
|
2004
|
0.75
|
|
65
|
Comparative outcomes of reduced intensity and myeloablative allogeneic hematopoietic stem cell transplantation in patients under 50 with hematologic malignancies.
|
Clin Transplant
|
2006
|
0.75
|
|
66
|
Anti-leukemic effect of 2-pyrone derivatives via MAPK and PI3 kinase pathways.
|
Invest New Drugs
|
2012
|
0.75
|
|
67
|
Quantity of clonal cells detected by conventional cytogenetic analysis correlates with bone marrow blasts and survival in myelodysplastic syndromes.
|
Leuk Res
|
2011
|
0.75
|
|
68
|
Pharmacokinetics and tolerability of intravenous busulfan in hematopoietic stem cell transplantation.
|
Clin Transplant
|
2007
|
0.75
|